...
首页> 外文期刊>Open Journal of Urology >Medical Expulsive Therapy (MET) for Large Distal Ureteral Stones: A Prospective Study Comparing Three Drugs
【24h】

Medical Expulsive Therapy (MET) for Large Distal Ureteral Stones: A Prospective Study Comparing Three Drugs

机译:用于大远侧输尿管的医学驱逐治疗(MET):一项比较三种药物的前瞻性研究

获取原文
           

摘要

Introduction: One of the most common disorders of the urinary tract is Urolithiasis. Twenty percent of lithiasis are located in the ureter of which 68% are seen in the distal ureter. The concept of medical expulsive therapy (MET) has been developed with enough knowledge of the ureter physiology in order to make easier the spontaneous expulsion of the stone. The aim of this study was to evaluate the efficacy and safety of three different drugs for the treatment of pelvic ureteral stones. Materiel and Methods: Between October 2017 and November 2018, 90 adult patients presenting with low or non-obstructive pelvic ureteral stones sized 8 to 10 mm were included. They were prospectively randomized, using computer-based randomization charts, into three equal groups: treatment with ketoprofen 100 mg once daily (Group I), silodosin 8 mg once daily (Group II) and tadalafil 5 mg once daily (Group III). The aim was to compare spontaneous expulsion of stone between those drugs Results: The mean expulsion time from the start of MET was 11.5 ± 3.27 days for ketoprofen group, 10.71 ± 3.98 days for silodosin group and 10.57 ± 3.40 days for tadalafil group. But these differences were also not significant (P = 0.79). The use of analgesics (grade II) was higher in groups II and III compared to group I, but without significant difference (23.33% in group I, 33.33% in group II and 40% in group III, p = 0.38). Discussion: The overall chance of spontaneous passage is low when the stone diameter is sized more than 7 mm. A wide range of spontaneous passage rates have been reported in the literature, varying from 71% to 98% for distal ureteral stones less than 5 mm and 25% - 53% for stone sized 5 to 10 mm with a mean expulsion time of more than 10 days. Conclusion: The three drugs have a low expulsion rate for 8, 9 and 10 mm pelvic ureteral stones with a higher adverse event rate for the NSAID group.
机译:简介:泌尿道最常见的疾病之一是尿道病。 20%的岩石病位于输尿管中,在远端输尿管中看到68%。已经开发了医学驱逐治疗(MET)的概念,具有足够的尿辨物理学知识,以便更容易地开除石头。本研究的目的是评估三种不同药物治疗盆腔输尿管的疗效和安全性。物资和方法:2017年10月和2018年11月期间,包括含有8至10毫米的低或非阻塞性盆腔输尿管的90例成年患者。他们经过前瞻性地随机化,将基于计算机的随机化图表分为三个相等的组:用酮洛芬100mg治疗一次每日一次(I族),硅二蛋白酶8mg每日一次(II族)和达拉非5毫克每日一次(III组)。目的是将这些药物之间的自发排出的石头进行比较:Ketoprofen组的均为11.5±3.27天,10.71±3.98天,硅霉素组10.57±3.40天。但这些差异也不重要(p = 0.79)。与I族II和III组,镇痛药(II级)的使用较高,但与I基团相比,但没有显着差异(II族,II族的23.33%,III组中的40%,P = 0.38)。讨论:当石头直径大于7毫米时,自发通道的总体机会很低。在文献中报告了广泛的自发通道率,对于远侧输尿管石块的71%至98%,石头大小为5至10毫米的远端输尿管石,而平均驱逐时间超过10天。结论:这三种药物具有8,9和10毫米盆腔输尿管的低驱逐率,对于NSAID组具有更高的不良事件率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号